The insolvent genetic analysis company 23andme is taken over by a pharmaceutical company that wants to continue the business ...

Pharmaceutical giant Regeneron has promised to prioritise the “ethical use” of the sequenced DNA data of more than 15 million ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Dow Jones Top Company Headlines at 7 PM ET: Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million | Jamie ... The DNA testing company would sell for a fraction of its peak valuation of $6 ...

Regeneron is buying 23andMe for $256M in bankruptcy, gaining access to DNA data from 15 million users to aid drug research.

The once-popular genetic testing company will be acquired by Regeneron after filing for bankruptcy, but the questions about ...

On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

Genetic testing company 23andMe isn’t going away, despite declaring bankruptcy. The company and nearly all of its assets, ...

The company, which was founded in 2006, rose to prominence by offering at-home DNA testing kits that allowed people to ...

Regeneron Pharmaceutical (REGN) is buying 23andMe’s (MEHCQ) genetics business out of bankruptcy for $256 million, aiming to ...